Fabrication and characterization of novel hybrid organic/inorganic microparticles to apply in bone regeneration

Journal of Biomedical Materials Research - Part A

Volumn 93, Issue 4, 2010, Pages 1280-1288

  Jayasuriya, A Champa ^a   Bhat, Archana ^a  

^a UNIVERSITY OF TOLEDO   (United States)

Author keywords

Bone regeneration; Chitosan; Hybrid organic inorganic; Injectable; Microparticles

Indexed keywords

AMINE GROUPS; BONE DEFECT; BONE REGENERATION; BONE TISSUE ENGINEERING; CROSS LINKING AGENTS; FTIR; INORGANIC COMPONENTS; MESENCHYMAL STEM CELL; MICRO-PARTICLES; ORGANIC/INORGANIC; PHOSPHATE GROUP; SCALE-UP; SEM IMAGE; TRIPOLYPHOSPHATES; XRD;

CALCIUM; CALCIUM ALLOYS; CALCIUM CARBONATE; CALCIUM PHOSPHATE; CELL CULTURE; CHITIN; CHITOSAN; CROSSLINKING; FABRICATION; FLOWCHARTING; FOURIER TRANSFORM INFRARED SPECTROSCOPY; STEM CELLS; TISSUE ENGINEERING; X RAY DIFFRACTION;

BONE;

CALCIUM CARBONATE; CALCIUM PHOSPHATE DIBASIC; CHITOSAN; TRIPOLYPHOSPHATE;

ANIMAL CELL; ARTICLE; BONE DEFECT; BONE REGENERATION; CELL ADHESION; CONTROLLED STUDY; CROSS LINKING; INFRARED SPECTROSCOPY; MALE; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL; MORPHOLOGY; MOUSE; NONHUMAN; SCALE UP; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; TISSUE ENGINEERING;

ANIMALS; BONE REGENERATION; CALCIUM CARBONATE; CELL ADHESION; CROSS-LINKING REAGENTS; HYDROGEN-ION CONCENTRATION; MALE; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; MODELS, CHEMICAL; POLYPHOSPHATES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TIME FACTORS;

EID: 77951615676     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32623     Document Type: Article

References (35)

1. Green J. The physicochemical structure of bone: cellular and noncellular elements. Miner Electrolyte Metab 1994;20:7-15. (Pubitemid 24087916)
2. Murray JF. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 5th ed. Washington DC: American Society for Bone and Mineral Research; 2003. p 46-58.
3. Gefen A, Neulander R. Computational determination of the critical microcrack size that causes a remodeling response in a trabecula: A feasibility study. J Appl Biomech 2007;23:230-237. (Pubitemid 47330930)
4. Laurell L, Gottlow J, Zybutz M, Oersson R. Treatment of intrabony defects by different surgical procedures: A literature review. J Periodontol 1998;69:303-313. (Pubitemid 128531932)
5. Greenwald SA, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN. Bone-graft substitutes: Facts, fictions, and applications. J Bone Joint Surg 2001;83:98-103.
6. Garcia-Godoy F, Murray PE. Status and potential commercial impact of stem cell-based treatments on dental and craniofacial regeneration. Stem Cells Dev 2006;15:881-887. (Pubitemid 46147859)
7. Friedlander GE. Currents concepts review: bone grafts: the basic science rationale for clinical applications. J Bone Joint Surg 1987;69:786-790.
8. Rees DC, Haddad FS. Bone transplantation. Hosp Med 2003;64:205-209.
9. Younger EM, Chapman MW. Morbidity at bone graft donor sites. J Ortho Trauma 1989;3:192-195.
10. Silber JS, Anderson DG, Daffner SD, Brislin BT, Leland JM, Hilibrand AS, Vaccaro AR, Albert TJ. Donor site morbidity after anterior iliac crest bone harvest for single-level anterior cervical discectomy and fusion. Spine 2003;28:134-139. (Pubitemid 36110079)
11. Boyce T, Edwards J, Scarborough N. Allograft bone. The influence of processing on safety and performance. Orthop Clin North Am 1999;30:571-581.
12. Khan Y, Yaszemski MJ, Mikos AG, Laurencin CT. Tissue engineering of bone: Material and matrix considerations. J Bone Joint Surg Am 2008;90(Suppl 1):36-42. (Pubitemid 351329119)
13. Xu HH, Quinn JB, Takagi S, Chow LC. Synergistic reinforcement of in situ hardening calcium phosphate composite scaffold for bone tissue engineering. Biomaterials 2004;25:1029-1037. (Pubitemid 37393294)
14. De Long WG, Einhorn TA, Koval K, Mckee M, Smith W, Sanders R, Watson T. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. J Bone Joint Surg Am 2007;89:649-658. (Pubitemid 46365369)
15. Gosain AK, Song L, Riordan P, Amarante MT, Nagy PG, Wilson CR, Toth JM, Ricci JL. A 1-year study of osteoinduction in hydroxyapatite-derived biomaterials in an adult sheep model: Part I. Plast Reconstr Surg 2002;109:619-630. (Pubitemid 34118431)
16. Payne RG, Yaszemski MJ, Yasko AW, Mikos AG. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles. Biomaterials 2002;23:4359-4371.
17. Kruyt MC, Persson C, Johansson G, Dhert WJ, De Bruijn JD. Towards injectable cell-based tissue-engineered bone: the effect of different calcium phosphate microparticles and preculturing. Tissue Eng 2006;12:309-317.
18. Kato Y, Onishi H, Machida Y. Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol 2003;4:303-309. (Pubitemid 37220862)
19. Kim IY, Seo SJ, Moon HS, Yoo MK, Park IY, Kim BC, Cho CS. Chitosan and its derivatives for tissue engineering applications. Biotechnol Adv 2008;26:1-21. (Pubitemid 350138341)
20. Di Martino A, Sittinger M, Risbud MV. Chitosan: A versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 2005;26:5983-5990. (Pubitemid 40805604)
21. Li Z, Ramay HR, Hauch KD, Xiao D, Zhang M. Chitosan-alginate hybrid scaffolds for bone tissue engineering. Biomaterials 2005;26:3919-3928. (Pubitemid 40038783)
22. Jayasuriya AC, Bhat A. Optimization of scaled-up chitosan microparticles for bone regeneration. Biomed Mater. Forthcoming.
23. Jayasuriya AC, Shah C. Controlled release of insulin-like growth factor-1 and bone marrow stromal cell function of bone-like mineral layer-coated poly(lactic-co-glycolic acid) scaffolds. J Tissue Eng Regen Med 2008;2:43-49.
24. Bhumkar DR, Pokharkar VB. Studies on effect of pH on cross-linking of CS with sodium tripolyphosphate: A technical note. AAPS PharmSciTech 2006;7:E50.
25. Wang X, Ma J, Wang Y, He B. Structural characterization of phosphorylated chitosan and their applications as effective additives of calcium phosphate cements. Biomaterials 2001;22:2247-2255. (Pubitemid 32591358)
26. Ooms EM, E. A. Egglezos EA, Jansen JA. Soft-tissue response to injectable calcium phosphate cements. Biomaterials 2003;24:749-757. (Pubitemid 35449827)
27. Conti B, Giunchedi P, Genta I, Conte U. The preparation and in vivo evaluation of the wound-healing properties of CS microspheres. STP Pharm Sci 2000;10:101-104. (Pubitemid 30126793)
28. Bohner M. Calcium orthophosphates in medicine: From ceramics to calcium phosphate cements. Injury 2000;31:D37-D47. (Pubitemid 32396942)
29. Muenzenberg K, Gebhardt M. Brushite, octocalcium phosphate, and carbonate-containing apatite in bone. Clin Orthop Relat Res 1973;90:271-273.
30. Huan Z, Chang J. Study on physicochemical properties and in vitro bioactivity of tricalcium silicate-calcium carbonate composite bone cement. J Mater Sci Mater Med 2008;19:2913-2918.
31. Leung HW. Ecotoxicology of glutaraldehyde: Review of environmental fate and effects studies. Ecotoxicol Environ Saf 2001;49:26-39. (Pubitemid 32473146)
32. Ballantyne B, Jordan SL. Toxicological, medical and industrial hygiene aspects of glutaraldehyde with particular reference to its biocidal use in cold sterilization procedures. J Appl Toxicol 2001;21:131-151. (Pubitemid 32288362)
33. Shu XZ, Zhu KJ. Controlled drug release properties of ionically cross-linked CS beads: The influence of anion structure. Int J Pharm 2002;233:217-225.
34. Lee JY, Choo JE, Park HJ, Park JB, Lee SC, Jo I, Lee SJ, Chung CP, Park YJ. Injectable gel with synthetic collagen-binding peptide for enhanced osteogenesis in vitro and in vivo. Biochem Biophys Res Commun 2007;357:68-74. (Pubitemid 46574501)
35. Latta LL, Sarmiento A, Zych GA. Principles of nonoperative fracture treatment. In: Browner BD, Jupiter JB, Levine AM, Trafton PG, editors. Skeletal Trauma: Basic Science, Management, and Reconstruction, 3rd ed. Philadelphia: Saunders; 2003. p 159-194.